Commercial property group British Land (BLND) has agreed to buy ailing Life Science REIT (LABS) for a small premium. The deal comes after LABS shareholders agreed to a managed wind-down of the company last November. BLND share price: 406p (-0.9%) PE: 7.4x Market cap: £4.1bn Yield: 5.6% ASSETS SUIT ‘CAMPUS’ STRATEGY In September 2025, Life … Continue reading British Land buys ailing Life Science REIT